Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef’s ability to antag...
Saved in:
Published in | Scientific reports Vol. 10; no. 1; p. 19416 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
10.11.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef’s ability to antagonize SERINC5 and thereby influence viral fitness in vivo
.
To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef’s ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo. |
---|---|
AbstractList | HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef's ability to antagonize SERINC5 and thereby influence viral fitness in vivo. To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef's ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo.HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef's ability to antagonize SERINC5 and thereby influence viral fitness in vivo. To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef's ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo. HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef’s ability to antagonize SERINC5 and thereby influence viral fitness in vivo . To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef’s ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo. HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due to the selective forces of host cellular immunity, we hypothesized that certain immune-escape polymorphisms may impair Nef's ability to antagonize SERINC5 and thereby influence viral fitness in vivo. To test this hypothesis, we identified 58 Nef polymorphisms that were overrepresented in HIV-infected patients in Japan sharing the same HLA genotypes. The number of immune-associated Nef polymorphisms was inversely correlated with the plasma viral load. By breaking down the specific HLA allele-associated mutations, we found that a number of the HLA-B*51:01-associated Y120F and Q125H mutations were most significantly associated with a reduced plasma viral load. A series of biochemical experiments showed that the double mutations Y120F/Q125H, but not either single mutation, impaired Nef's ability to antagonize SERINC5 and was associated with decreasing virion infectivity and viral replication in primary lymphocytes. In contrast, other Nef functions such as CD4, CCR5, CXCR4 and HLA class I downregulation and CD74 upregulation remained unchanged. Taken together, our results suggest that the differential ability of Nef to counteract SERINC5 by naturally occurring immune-associated mutations was associated with the plasma viral load in vivo. |
ArticleNumber | 19416 |
Author | Kamori, Doreen Tan, Toong Seng Carlson, Jonathan Kawana-Tachikawa, Ai Oka, Shinichi Pizzato, Massimo Ueno, Takamasa Ohashi, Jun Toyoda, Mako Goebuchi, Kageaki Gatanaga, Hiroyuki |
Author_xml | – sequence: 1 givenname: Mako surname: Toyoda fullname: Toyoda, Mako organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University – sequence: 2 givenname: Doreen surname: Kamori fullname: Kamori, Doreen organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University – sequence: 3 givenname: Toong Seng surname: Tan fullname: Tan, Toong Seng organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University – sequence: 4 givenname: Kageaki surname: Goebuchi fullname: Goebuchi, Kageaki organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University – sequence: 5 givenname: Jun surname: Ohashi fullname: Ohashi, Jun organization: University of Tokyo – sequence: 6 givenname: Jonathan surname: Carlson fullname: Carlson, Jonathan organization: Microsoft Research – sequence: 7 givenname: Ai surname: Kawana-Tachikawa fullname: Kawana-Tachikawa, Ai organization: AIDS Research Center, National Institute of Infectious Diseases – sequence: 8 givenname: Hiroyuki surname: Gatanaga fullname: Gatanaga, Hiroyuki organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University, National Center for Global Health and Medicine – sequence: 9 givenname: Shinichi surname: Oka fullname: Oka, Shinichi organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University, National Center for Global Health and Medicine – sequence: 10 givenname: Massimo surname: Pizzato fullname: Pizzato, Massimo organization: Department of Cellular, Computational and Integrative Biology, University of Trento – sequence: 11 givenname: Takamasa surname: Ueno fullname: Ueno, Takamasa email: uenotaka@kumamoto-u.ac.jp organization: Joint Research Center for Human Retrovirus Infection, Kumamoto University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33173092$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV1rHCEYhaUkNB_NH-hFEXqTm2n83Jm5KZQlTRZCCv26FVdfE8OMbtXZJf--bjdp01xEkFfxOYcj5wjthRgAobeUfKCEd2dZUNl3DWGkaWe8lc3mFTpkRMiGccb2npwP0EnOd6QuyXpB-9fogHPactKzQ5QX40r7BBbrpR98ucfR4WtwuERs4hQKJG0K_nb-dXE9l9hnrHOOxutSJRtfbnHVTqZeVoPOo8brajZ6jX3Al4ufjQ8OzJb1wfq1t5Me8hu07-qAk4d5jH58Pv8-v2yuvlws5p-uGiNaURomaSctsyBbEC1QYh1YIbQl0rTQCWOXkvTgDLjOUeGkNMz0XFDBOUgj-TH6uPNdTcsRrIFQkh7UKvlRp3sVtVf_vwR_q27iWrUzOWOSVIPTB4MUf02Qixp9NjAMOkCcsmJC9hXsGKvo-2foXZxSqN-rVEulrLuv1Lunif5GeeyjAt0OMCnmnMAp44suPm4D-kFRorbtq137qrav_rSvNlXKnkkf3V8U8Z0oVzjcQPoX-wXVbzoLw4o |
CitedBy_id | crossref_primary_10_1186_s12977_023_00618_7 crossref_primary_10_1371_journal_ppat_1010907 crossref_primary_10_3389_fcell_2022_856468 crossref_primary_10_1007_s00430_022_00732_x crossref_primary_10_1128_jvi_00823_23 crossref_primary_10_1089_aid_2021_0055 crossref_primary_10_3390_v16020284 crossref_primary_10_3389_fcimb_2024_1516806 crossref_primary_10_1128_JVI_00634_21 |
Cites_doi | 10.1093/bioinformatics/bti079 10.4049/jimmunol.1100316 10.1016/j.bbrc.2015.05.038 10.1073/pnas.0607622104 10.1371/journal.ppat.0030094 10.1074/jbc.M117.777714 10.1038/Nm0396-338 10.1128/JVI.69.1.579-584.1995 10.1128/Jvi.79.1.632-636.2005 10.1128/jvi.00904-07 10.1016/0092-8674(94)90360-3 10.1007/s13365-010-0001-6 10.1016/j.virol.2013.02.005 10.1126/science.270.5238.988 10.1097/QAD.0000000000002559 10.1186/1742-4690-10-100 10.1186/1742-4690-10-1 10.1099/vir.0.81775-0 10.1084/jem.179.1.101 10.1016/j.chom.2016.08.004 10.1016/j.virol.2014.08.009 10.1016/0092-8674(91)90097-i 10.1016/j.jviromet.2008.10.012 10.1016/j.virol.2006.03.044 10.1007/s00705-015-2480-5 10.1128/jvi.74.6.2907-2912.2000 10.1186/s12977-019-0510-1 10.1007/s00251-005-0048-3 10.1128/JVI.69.8.5048-5056.1995 10.1016/j.bbrc.2012.04.002 10.1186/1742-4690-8-50 10.7554/eLife.01754 10.1128/JVI.01998-12 10.1128/jvi.77.23.12430-12440.2003 10.1128/mBio.01516-15 10.1128/JVI.01246-16 10.1371/journal.pcbi.1000225 10.1038/nature15399 10.3390/cells8091020 10.1016/j.cub.2005.02.058 10.1128/jvi.01556-06 10.1128/jvi.77.19.10548-10556.2003 10.4049/jimmunol.178.9.5513 10.1093/emboj/16.23.6964 10.1038/nature15400 10.1128/jvi.77.2.1589-1594.2003 10.1016/j.jmb.2017.12.008 10.1126/science.1069660 10.1016/j.micinf.2009.09.009 10.1128/jvi.74.11.5310-5319.2000 10.1038/35004038 10.1186/1742-4690-9-s2-p269 10.1099/jgv.0.001201 10.1371/journal.pone.0006687 10.1128/JVI.68.5.2906-2914.1994 10.1016/j.celrep.2019.10.007 10.1128/JVI.01409-17 10.1016/j.jmb.2009.09.047 10.1074/jbc.M000536200 10.1128/JVI.01334-14 10.1128/JVI.01874-07 10.1128/JVI.01548-15 10.4049/jimmunol.180.2.1107 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.1038/s41598-020-76375-w |
DatabaseName | Springer Nature OA Free Journals (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
ExternalDocumentID | PMC7656250 33173092 10_1038_s41598_020_76375_w |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development funderid: http://dx.doi.org/10.13039/100009619 – fundername: Japan Society for the Promotion of Science funderid: http://dx.doi.org/10.13039/501100001691 – fundername: ; |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c474t-25185d2de57e47e10dfed44ad05c7e84cdb509efcef8f14f55c2c9341433e5c53 |
IEDL.DBID | 7X7 |
ISSN | 2045-2322 |
IngestDate | Thu Aug 21 13:32:31 EDT 2025 Tue Aug 05 11:30:13 EDT 2025 Wed Aug 13 02:52:26 EDT 2025 Thu Apr 03 06:59:11 EDT 2025 Tue Jul 01 02:46:50 EDT 2025 Thu Apr 24 22:59:35 EDT 2025 Fri Feb 21 02:38:52 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-25185d2de57e47e10dfed44ad05c7e84cdb509efcef8f14f55c2c9341433e5c53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2471557159?pq-origsite=%requestingapplication% |
PMID | 33173092 |
PQID | 2471557159 |
PQPubID | 2041939 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7656250 proquest_miscellaneous_2459625822 proquest_journals_2471557159 pubmed_primary_33173092 crossref_citationtrail_10_1038_s41598_020_76375_w crossref_primary_10_1038_s41598_020_76375_w springer_journals_10_1038_s41598_020_76375_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-11-10 |
PublicationDateYYYYMMDD | 2020-11-10 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Jin (CR23) 2019; 29 Fackler (CR39) 2006; 351 Venzke, Michel, Allespach, Fackler, Keppler (CR5) 2006; 80 Lindwasser (CR40) 2008; 82 Greenberg (CR16) 1997; 16 Mwimanzi (CR43) 2013; 439 Heigele (CR51) 2016; 20 Liu (CR32) 2000; 74 Casartelli (CR38) 2006; 87 Akari (CR15) 2000; 74 Mahiti, Brumme, Jessen, Brockman, Ueno (CR56) 2015; 463 Jere, Fujita, Adachi, Nomaguchi (CR49) 2010; 12 Ueno, Idegami, Motozono, Oka, Takiguchi (CR55) 2007; 178 Yamada (CR19) 2003; 77 Carlson (CR28) 2012; 86 Mwimanzi (CR57) 2013; 10 Miller, Warmerdam, Gaston, Greene, Feinberg (CR7) 1994; 179 Schindler (CR6) 2003; 77 Miller, Warmerdam, Page, Feinberg, Greene (CR11) 1995; 69 Pond, Frost, Muse (CR54) 2005; 21 Kestler (CR1) 1991; 65 Sudderuddin (CR37) 2020; 17 Ren, Park, Bonifacino, Hurley (CR18) 2014; 3 Mwimanzi (CR58) 2011; 8 Mann (CR42) 2013; 10 Pizzato (CR60) 2009; 156 de Sousa-Pereira (CR52) 2019; 100 Sood, Marin, Chande, Pizzato, Melikyan (CR14) 2017; 292 Hasan (CR24) 2012; 421 Williams, Roeth, Kasper, Filzen, Collins (CR31) 2005; 79 Schwartz, Marechal, LeGall, Lemonnier, Heard (CR8) 1996; 2 Mann (CR45) 2014; 468–470 Moore (CR63) 2002; 296 Moroco (CR50) 2018; 430 Toyoda (CR46) 2015; 89 Deacon (CR2) 1995; 270 Itoh (CR25) 2005; 57 Brumme (CR21) 2007; 3 Zhang (CR29) 2011; 187 Carlson (CR27) 2008; 4 Pizzato (CR33) 2007; 104 Trautz (CR61) 2016; 90 Brumme (CR62) 2009; 4 Gray (CR41) 2011; 17 Ueno (CR22) 2008; 180 Geels (CR30) 2003; 77 Aiken, Konner, Landau, Lenburg, Trono (CR3) 1994; 76 Chowers (CR9) 1994; 68 Mahiti (CR59) 2016; 7 Mwimanzi (CR47) 2018 Poe, Smithgall (CR48) 2009; 394 Chikata (CR26) 2012; 9 Piguet (CR17) 2000; 2 Michel, Allespach, Venzke, Fackler, Keppler (CR4) 2005; 15 Rosa (CR12) 2015; 526 Münch (CR35) 2007; 81 Meribe (CR53) 2015; 160 Usami, Wu, Gottlinger (CR13) 2015; 526 Cohen, Rangan, Chen, Smith, Baltimore (CR34) 2000; 275 Aiken, Trono (CR10) 1995; 69 Mwimanzi (CR36) 2020; 34 Ramirez (CR20) 2019 Kuang (CR44) 2014; 88 J Münch (76375_CR35) 2007; 81 SW Jin (76375_CR23) 2019; 29 A Jere (76375_CR49) 2010; 12 P Mwimanzi (76375_CR58) 2011; 8 MY Chowers (76375_CR9) 1994; 68 JM Carlson (76375_CR28) 2012; 86 M Mahiti (76375_CR56) 2015; 463 T Yamada (76375_CR19) 2003; 77 LX Liu (76375_CR32) 2000; 74 T Chikata (76375_CR26) 2012; 9 SC Meribe (76375_CR53) 2015; 160 SL Pond (76375_CR54) 2005; 21 MD Miller (76375_CR11) 1995; 69 NJ Deacon (76375_CR2) 1995; 270 N Michel (76375_CR4) 2005; 15 OT Fackler (76375_CR39) 2006; 351 Y Itoh (76375_CR25) 2005; 57 M Mahiti (76375_CR59) 2016; 7 Z Hasan (76375_CR24) 2012; 421 B Trautz (76375_CR61) 2016; 90 Y Usami (76375_CR13) 2015; 526 T Ueno (76375_CR22) 2008; 180 ZL Brumme (76375_CR21) 2007; 3 M Williams (76375_CR31) 2005; 79 Y Zhang (76375_CR29) 2011; 187 OW Lindwasser (76375_CR40) 2008; 82 CB Moore (76375_CR63) 2002; 296 GB Cohen (76375_CR34) 2000; 275 C Aiken (76375_CR3) 1994; 76 C Sood (76375_CR14) 2017; 292 ME Greenberg (76375_CR16) 1997; 16 P Mwimanzi (76375_CR57) 2013; 10 HW Kestler 3rd (76375_CR1) 1991; 65 V Piguet (76375_CR17) 2000; 2 JM Carlson (76375_CR27) 2008; 4 S Venzke (76375_CR5) 2006; 80 M Schindler (76375_CR6) 2003; 77 C Aiken (76375_CR10) 1995; 69 M Toyoda (76375_CR46) 2015; 89 A Rosa (76375_CR12) 2015; 526 H Akari (76375_CR15) 2000; 74 P Mwimanzi (76375_CR43) 2013; 439 A Heigele (76375_CR51) 2016; 20 H Sudderuddin (76375_CR37) 2020; 17 JA Moroco (76375_CR50) 2018; 430 MD Miller (76375_CR7) 1994; 179 M Pizzato (76375_CR33) 2007; 104 LR Gray (76375_CR41) 2011; 17 JA Poe (76375_CR48) 2009; 394 XT Kuang (76375_CR44) 2014; 88 T Ueno (76375_CR55) 2007; 178 JK Mann (76375_CR45) 2014; 468–470 F Mwimanzi (76375_CR47) 2018 O Schwartz (76375_CR8) 1996; 2 N Casartelli (76375_CR38) 2006; 87 ZL Brumme (76375_CR62) 2009; 4 P de Sousa-Pereira (76375_CR52) 2019; 100 JK Mann (76375_CR42) 2013; 10 PW Ramirez (76375_CR20) 2019 F Mwimanzi (76375_CR36) 2020; 34 M Pizzato (76375_CR60) 2009; 156 MJ Geels (76375_CR30) 2003; 77 X Ren (76375_CR18) 2014; 3 |
References_xml | – volume: 21 start-page: 676 year: 2005 end-page: 679 ident: CR54 article-title: HyPhy: Hypothesis testing using phylogenies publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti079 – volume: 187 start-page: 684 year: 2011 end-page: 691 ident: CR29 article-title: Multilayered defense in HLA-B51-associated HIV viral control publication-title: J. Immunol. doi: 10.4049/jimmunol.1100316 – volume: 463 start-page: 248 year: 2015 end-page: 254 ident: CR56 article-title: Dynamic range of Nef-mediated evasion of HLA class II-restricted immune responses in early HIV-1 infection publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.05.038 – volume: 104 start-page: 6812 year: 2007 end-page: 6817 ident: CR33 article-title: Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0607622104 – volume: 3 start-page: e94 year: 2007 ident: CR21 article-title: Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.0030094 – volume: 292 start-page: 6014 year: 2017 end-page: 6026 ident: CR14 article-title: SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins publication-title: J. Biol. Chem. doi: 10.1074/jbc.M117.777714 – volume: 2 start-page: 338 year: 1996 end-page: 342 ident: CR8 article-title: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein publication-title: Nat. Med. doi: 10.1038/Nm0396-338 – volume: 69 start-page: 579 year: 1995 end-page: 584 ident: CR11 article-title: Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry publication-title: J. Virol. doi: 10.1128/JVI.69.1.579-584.1995 – volume: 79 start-page: 632 year: 2005 end-page: 636 ident: CR31 article-title: Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2 publication-title: J. Virol. doi: 10.1128/Jvi.79.1.632-636.2005 – volume: 81 start-page: 13852 year: 2007 end-page: 13864 ident: CR35 article-title: Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses publication-title: J. Virol. doi: 10.1128/jvi.00904-07 – volume: 76 start-page: 853 year: 1994 end-page: 864 ident: CR3 article-title: Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain publication-title: Cell doi: 10.1016/0092-8674(94)90360-3 – volume: 17 start-page: 82 year: 2011 end-page: 91 ident: CR41 article-title: CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates publication-title: J. Neurovirol. doi: 10.1007/s13365-010-0001-6 – volume: 439 start-page: 74 year: 2013 end-page: 80 ident: CR43 article-title: Dynamic range of Nef functions in chronic HIV-1 infection publication-title: Virology doi: 10.1016/j.virol.2013.02.005 – volume: 270 start-page: 988 year: 1995 end-page: 991 ident: CR2 article-title: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients publication-title: Science doi: 10.1126/science.270.5238.988 – volume: 34 start-page: 1325 year: 2020 end-page: 1330 ident: CR36 article-title: An HIV-1 Nef genotype that diminishes immune control mediated by protective human leucocyte antigen alleles publication-title: Aids doi: 10.1097/QAD.0000000000002559 – volume: 10 start-page: 100 year: 2013 ident: CR42 article-title: Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes publication-title: Retrovirology doi: 10.1186/1742-4690-10-100 – volume: 10 start-page: 1 year: 2013 ident: CR57 article-title: Attenuation of multiple Nef functions in HIV-1 elite controllers publication-title: Retrovirology doi: 10.1186/1742-4690-10-1 – volume: 87 start-page: 2291 year: 2006 end-page: 2296 ident: CR38 article-title: The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner publication-title: J. Gen. Virol. doi: 10.1099/vir.0.81775-0 – volume: 179 start-page: 101 year: 1994 end-page: 113 ident: CR7 article-title: The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages publication-title: J. Exp. Med. doi: 10.1084/jem.179.1.101 – volume: 20 start-page: 381 year: 2016 end-page: 391 ident: CR51 article-title: The potency of Nef-mediated SERINC5 antagonism correlates with the prevalence of primate lentiviruses in the wild publication-title: Cell Host Microbe doi: 10.1016/j.chom.2016.08.004 – volume: 468–470 start-page: 214 year: 2014 end-page: 225 ident: CR45 article-title: Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: Association with disease progression and influence of immune pressure publication-title: Virology doi: 10.1016/j.virol.2014.08.009 – volume: 65 start-page: 651 year: 1991 end-page: 662 ident: CR1 article-title: Importance of the nef gene for maintenance of high virus loads and for development of AIDS publication-title: Cell doi: 10.1016/0092-8674(91)90097-i – volume: 156 start-page: 1 year: 2009 end-page: 7 ident: CR60 article-title: A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2008.10.012 – volume: 351 start-page: 322 year: 2006 end-page: 339 ident: CR39 article-title: Functional characterization of HIV-1 Nef mutants in the context of viral infection publication-title: Virology doi: 10.1016/j.virol.2006.03.044 – volume: 160 start-page: 2033 year: 2015 end-page: 2041 ident: CR53 article-title: Association between a naturally arising polymorphism within a functional region of HIV-1 Nef and disease progression in chronic HIV-1 infection publication-title: Arch. Virol. doi: 10.1007/s00705-015-2480-5 – volume: 74 start-page: 2907 year: 2000 end-page: 2912 ident: CR15 article-title: Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation publication-title: J. Virol. doi: 10.1128/jvi.74.6.2907-2912.2000 – volume: 17 start-page: 3 year: 2020 ident: CR37 article-title: Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: A case study publication-title: Retrovirology doi: 10.1186/s12977-019-0510-1 – volume: 57 start-page: 717 year: 2005 end-page: 729 ident: CR25 article-title: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population publication-title: Immunogenetics doi: 10.1007/s00251-005-0048-3 – volume: 69 start-page: 5048 year: 1995 end-page: 5056 ident: CR10 article-title: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis publication-title: J. Virol. doi: 10.1128/JVI.69.8.5048-5056.1995 – volume: 421 start-page: 291 year: 2012 end-page: 295 ident: CR24 article-title: Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2012.04.002 – volume: 8 start-page: 50 year: 2011 ident: CR58 article-title: Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages publication-title: Retrovirology doi: 10.1186/1742-4690-8-50 – volume: 3 start-page: e01754 year: 2014 ident: CR18 article-title: How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4 publication-title: Elife doi: 10.7554/eLife.01754 – volume: 86 start-page: 13202 year: 2012 end-page: 13216 ident: CR28 article-title: Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1 publication-title: J. Virol. doi: 10.1128/JVI.01998-12 – volume: 77 start-page: 12430 year: 2003 end-page: 12440 ident: CR30 article-title: Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual publication-title: J. Virol. doi: 10.1128/jvi.77.23.12430-12440.2003 – volume: 7 start-page: e01516 year: 2016 ident: CR59 article-title: Relative resistance of HLA-B to downregulation by naturally occurring HIV-1 Nef sequences publication-title: mBio doi: 10.1128/mBio.01516-15 – volume: 90 start-page: 10915 year: 2016 end-page: 10927 ident: CR61 article-title: The antagonism of HIV-1 Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor publication-title: J. Virol. doi: 10.1128/JVI.01246-16 – volume: 4 start-page: e1000225 year: 2008 ident: CR27 article-title: Phylogenetic dependency networks: Inferring patterns of CTL escape and codon covariation in HIV-1 Gag publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1000225 – volume: 526 start-page: 212 year: 2015 end-page: 217 ident: CR12 article-title: HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation publication-title: Nature doi: 10.1038/nature15399 – year: 2019 ident: CR20 article-title: Plasma membrane-associated restriction factors and their counteraction by HIV-1 accessory proteins publication-title: Cells doi: 10.3390/cells8091020 – volume: 15 start-page: 714 year: 2005 end-page: 723 ident: CR4 article-title: The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4 publication-title: Curr. Biol. doi: 10.1016/j.cub.2005.02.058 – volume: 80 start-page: 11141 year: 2006 end-page: 11152 ident: CR5 article-title: Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection publication-title: J. Virol. doi: 10.1128/jvi.01556-06 – volume: 77 start-page: 10548 year: 2003 end-page: 10556 ident: CR6 article-title: Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles publication-title: J. Virol. doi: 10.1128/jvi.77.19.10548-10556.2003 – volume: 178 start-page: 5513 year: 2007 end-page: 5523 ident: CR55 article-title: Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs publication-title: J. Immunol. doi: 10.4049/jimmunol.178.9.5513 – volume: 16 start-page: 6964 year: 1997 end-page: 6976 ident: CR16 article-title: Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation publication-title: J. Article doi: 10.1093/emboj/16.23.6964 – volume: 526 start-page: 218 year: 2015 end-page: 223 ident: CR13 article-title: SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef publication-title: Nature doi: 10.1038/nature15400 – volume: 77 start-page: 1589 year: 2003 end-page: 1594 ident: CR19 article-title: Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen publication-title: J. Virol. doi: 10.1128/jvi.77.2.1589-1594.2003 – volume: 430 start-page: 310 year: 2018 end-page: 321 ident: CR50 article-title: Remodeling of HIV-1 Nef structure by Src-family kinase binding publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2017.12.008 – volume: 296 start-page: 1439 year: 2002 end-page: 1443 ident: CR63 article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level publication-title: Science doi: 10.1126/science.1069660 – volume: 12 start-page: 65 year: 2010 end-page: 70 ident: CR49 article-title: Role of HIV-1 Nef protein for virus replication in vitro publication-title: Microbes Infect. doi: 10.1016/j.micinf.2009.09.009 – volume: 74 start-page: 5310 year: 2000 end-page: 5319 ident: CR32 article-title: Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions publication-title: J. Virol. doi: 10.1128/jvi.74.11.5310-5319.2000 – volume: 2 start-page: 163 year: 2000 end-page: 167 ident: CR17 article-title: HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes publication-title: Nat. Cell Biol. doi: 10.1038/35004038 – volume: 9 start-page: P269 year: 2012 ident: CR26 article-title: HLA-associated viral polymorphism in chronically HIV-1-infected Japanese cohort: Analysis of four-digit HLA allele level publication-title: Retrovirology doi: 10.1186/1742-4690-9-s2-p269 – volume: 100 start-page: 278 year: 2019 end-page: 288 ident: CR52 article-title: The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001201 – volume: 4 start-page: e6687 year: 2009 ident: CR62 article-title: HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins publication-title: PloS ONE doi: 10.1371/journal.pone.0006687 – volume: 68 start-page: 2906 year: 1994 end-page: 2914 ident: CR9 article-title: Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene publication-title: J. Virol. doi: 10.1128/JVI.68.5.2906-2914.1994 – volume: 29 start-page: 1449 year: 2019 end-page: 1457 ident: CR23 article-title: Natural HIV-1 Nef polymorphisms impair SERINC5 downregulation activity publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.10.007 – year: 2018 ident: CR47 article-title: Resistance of major histocompatibility complex class B (MHC-B) to Nef-mediated downregulation relative to that of MHC-A is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals publication-title: J. Virol. doi: 10.1128/JVI.01409-17 – volume: 394 start-page: 329 year: 2009 end-page: 342 ident: CR48 article-title: HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2009.09.047 – volume: 275 start-page: 23097 year: 2000 end-page: 23105 ident: CR34 article-title: The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation publication-title: J. Biol. Chem. doi: 10.1074/jbc.M000536200 – volume: 88 start-page: 10200 year: 2014 end-page: 10213 ident: CR44 article-title: Impaired Nef function is associated with early control of HIV-1 viremia publication-title: J. Virol. doi: 10.1128/JVI.01334-14 – volume: 82 start-page: 1166 year: 2008 end-page: 1174 ident: CR40 article-title: A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2 publication-title: J. Virol. doi: 10.1128/JVI.01874-07 – volume: 89 start-page: 9639 year: 2015 end-page: 9652 ident: CR46 article-title: Differential ability of primary HIV-1 Nef isolates to downregulate HIV-1 entry receptors publication-title: J. Virol. doi: 10.1128/JVI.01548-15 – volume: 180 start-page: 1107 year: 2008 end-page: 1116 ident: CR22 article-title: CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef publication-title: J. Immunol. doi: 10.4049/jimmunol.180.2.1107 – volume: 17 start-page: 82 year: 2011 ident: 76375_CR41 publication-title: J. Neurovirol. doi: 10.1007/s13365-010-0001-6 – volume: 65 start-page: 651 year: 1991 ident: 76375_CR1 publication-title: Cell doi: 10.1016/0092-8674(91)90097-i – volume: 21 start-page: 676 year: 2005 ident: 76375_CR54 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti079 – volume: 421 start-page: 291 year: 2012 ident: 76375_CR24 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2012.04.002 – year: 2018 ident: 76375_CR47 publication-title: J. Virol. doi: 10.1128/JVI.01409-17 – volume: 86 start-page: 13202 year: 2012 ident: 76375_CR28 publication-title: J. Virol. doi: 10.1128/JVI.01998-12 – volume: 394 start-page: 329 year: 2009 ident: 76375_CR48 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2009.09.047 – volume: 439 start-page: 74 year: 2013 ident: 76375_CR43 publication-title: Virology doi: 10.1016/j.virol.2013.02.005 – volume: 68 start-page: 2906 year: 1994 ident: 76375_CR9 publication-title: J. Virol. doi: 10.1128/JVI.68.5.2906-2914.1994 – volume: 187 start-page: 684 year: 2011 ident: 76375_CR29 publication-title: J. Immunol. doi: 10.4049/jimmunol.1100316 – volume: 9 start-page: P269 year: 2012 ident: 76375_CR26 publication-title: Retrovirology doi: 10.1186/1742-4690-9-s2-p269 – volume: 69 start-page: 579 year: 1995 ident: 76375_CR11 publication-title: J. Virol. doi: 10.1128/JVI.69.1.579-584.1995 – volume: 430 start-page: 310 year: 2018 ident: 76375_CR50 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2017.12.008 – volume: 292 start-page: 6014 year: 2017 ident: 76375_CR14 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M117.777714 – volume: 34 start-page: 1325 year: 2020 ident: 76375_CR36 publication-title: Aids doi: 10.1097/QAD.0000000000002559 – volume: 351 start-page: 322 year: 2006 ident: 76375_CR39 publication-title: Virology doi: 10.1016/j.virol.2006.03.044 – volume: 270 start-page: 988 year: 1995 ident: 76375_CR2 publication-title: Science doi: 10.1126/science.270.5238.988 – volume: 104 start-page: 6812 year: 2007 ident: 76375_CR33 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0607622104 – volume: 7 start-page: e01516 year: 2016 ident: 76375_CR59 publication-title: mBio doi: 10.1128/mBio.01516-15 – volume: 89 start-page: 9639 year: 2015 ident: 76375_CR46 publication-title: J. Virol. doi: 10.1128/JVI.01548-15 – volume: 16 start-page: 6964 year: 1997 ident: 76375_CR16 publication-title: J. Article doi: 10.1093/emboj/16.23.6964 – volume: 10 start-page: 1 year: 2013 ident: 76375_CR57 publication-title: Retrovirology doi: 10.1186/1742-4690-10-1 – volume: 82 start-page: 1166 year: 2008 ident: 76375_CR40 publication-title: J. Virol. doi: 10.1128/JVI.01874-07 – volume: 160 start-page: 2033 year: 2015 ident: 76375_CR53 publication-title: Arch. Virol. doi: 10.1007/s00705-015-2480-5 – volume: 4 start-page: e1000225 year: 2008 ident: 76375_CR27 publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1000225 – volume: 57 start-page: 717 year: 2005 ident: 76375_CR25 publication-title: Immunogenetics doi: 10.1007/s00251-005-0048-3 – volume: 90 start-page: 10915 year: 2016 ident: 76375_CR61 publication-title: J. Virol. doi: 10.1128/JVI.01246-16 – volume: 29 start-page: 1449 year: 2019 ident: 76375_CR23 publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.10.007 – volume: 296 start-page: 1439 year: 2002 ident: 76375_CR63 publication-title: Science doi: 10.1126/science.1069660 – volume: 180 start-page: 1107 year: 2008 ident: 76375_CR22 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.2.1107 – volume: 17 start-page: 3 year: 2020 ident: 76375_CR37 publication-title: Retrovirology doi: 10.1186/s12977-019-0510-1 – volume: 77 start-page: 12430 year: 2003 ident: 76375_CR30 publication-title: J. Virol. doi: 10.1128/jvi.77.23.12430-12440.2003 – volume: 15 start-page: 714 year: 2005 ident: 76375_CR4 publication-title: Curr. Biol. doi: 10.1016/j.cub.2005.02.058 – volume: 20 start-page: 381 year: 2016 ident: 76375_CR51 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2016.08.004 – volume: 10 start-page: 100 year: 2013 ident: 76375_CR42 publication-title: Retrovirology doi: 10.1186/1742-4690-10-100 – volume: 8 start-page: 50 year: 2011 ident: 76375_CR58 publication-title: Retrovirology doi: 10.1186/1742-4690-8-50 – volume: 12 start-page: 65 year: 2010 ident: 76375_CR49 publication-title: Microbes Infect. doi: 10.1016/j.micinf.2009.09.009 – volume: 468–470 start-page: 214 year: 2014 ident: 76375_CR45 publication-title: Virology doi: 10.1016/j.virol.2014.08.009 – volume: 87 start-page: 2291 year: 2006 ident: 76375_CR38 publication-title: J. Gen. Virol. doi: 10.1099/vir.0.81775-0 – volume: 100 start-page: 278 year: 2019 ident: 76375_CR52 publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001201 – volume: 2 start-page: 338 year: 1996 ident: 76375_CR8 publication-title: Nat. Med. doi: 10.1038/Nm0396-338 – volume: 178 start-page: 5513 year: 2007 ident: 76375_CR55 publication-title: J. Immunol. doi: 10.4049/jimmunol.178.9.5513 – volume: 76 start-page: 853 year: 1994 ident: 76375_CR3 publication-title: Cell doi: 10.1016/0092-8674(94)90360-3 – volume: 88 start-page: 10200 year: 2014 ident: 76375_CR44 publication-title: J. Virol. doi: 10.1128/JVI.01334-14 – volume: 275 start-page: 23097 year: 2000 ident: 76375_CR34 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M000536200 – volume: 3 start-page: e94 year: 2007 ident: 76375_CR21 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.0030094 – volume: 4 start-page: e6687 year: 2009 ident: 76375_CR62 publication-title: PloS ONE doi: 10.1371/journal.pone.0006687 – volume: 80 start-page: 11141 year: 2006 ident: 76375_CR5 publication-title: J. Virol. doi: 10.1128/jvi.01556-06 – volume: 69 start-page: 5048 year: 1995 ident: 76375_CR10 publication-title: J. Virol. doi: 10.1128/JVI.69.8.5048-5056.1995 – volume: 526 start-page: 218 year: 2015 ident: 76375_CR13 publication-title: Nature doi: 10.1038/nature15400 – volume: 77 start-page: 1589 year: 2003 ident: 76375_CR19 publication-title: J. Virol. doi: 10.1128/jvi.77.2.1589-1594.2003 – volume: 2 start-page: 163 year: 2000 ident: 76375_CR17 publication-title: Nat. Cell Biol. doi: 10.1038/35004038 – volume: 3 start-page: e01754 year: 2014 ident: 76375_CR18 publication-title: Elife doi: 10.7554/eLife.01754 – volume: 526 start-page: 212 year: 2015 ident: 76375_CR12 publication-title: Nature doi: 10.1038/nature15399 – volume: 179 start-page: 101 year: 1994 ident: 76375_CR7 publication-title: J. Exp. Med. doi: 10.1084/jem.179.1.101 – year: 2019 ident: 76375_CR20 publication-title: Cells doi: 10.3390/cells8091020 – volume: 463 start-page: 248 year: 2015 ident: 76375_CR56 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.05.038 – volume: 156 start-page: 1 year: 2009 ident: 76375_CR60 publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2008.10.012 – volume: 77 start-page: 10548 year: 2003 ident: 76375_CR6 publication-title: J. Virol. doi: 10.1128/jvi.77.19.10548-10556.2003 – volume: 74 start-page: 5310 year: 2000 ident: 76375_CR32 publication-title: J. Virol. doi: 10.1128/jvi.74.11.5310-5319.2000 – volume: 74 start-page: 2907 year: 2000 ident: 76375_CR15 publication-title: J. Virol. doi: 10.1128/jvi.74.6.2907-2912.2000 – volume: 79 start-page: 632 year: 2005 ident: 76375_CR31 publication-title: J. Virol. doi: 10.1128/Jvi.79.1.632-636.2005 – volume: 81 start-page: 13852 year: 2007 ident: 76375_CR35 publication-title: J. Virol. doi: 10.1128/jvi.00904-07 |
SSID | ssj0000529419 |
Score | 2.3660448 |
Snippet | HIV-1 Nef plays an essential role in enhancing virion infectivity by antagonizing the host restriction molecule SERINC5. Because Nef is highly polymorphic due... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 19416 |
SubjectTerms | 631/250/255/1901 631/326/596/1787 631/326/596/2555 631/326/596/2557 631/326/596/2558 CCR5 protein CD4 antigen CD4 Antigens - metabolism Cell Line Cell-mediated immunity Cells, Cultured CXCR4 protein Genotypes Histocompatibility antigen HLA HIV HIV Infections - metabolism HIV Infections - pathology HIV-1 - pathogenicity HLA-B Antigens - genetics HLA-B Antigens - metabolism Human immunodeficiency virus Humanities and Social Sciences Humans Immune Evasion - genetics Immune Evasion - physiology Infectivity Leukocytes, Mononuclear - metabolism Lymphocytes Membrane Glycoproteins - genetics Membrane Glycoproteins - metabolism Membrane Proteins - genetics Membrane Proteins - metabolism multidisciplinary Mutation nef Gene Products, Human Immunodeficiency Virus - genetics nef Gene Products, Human Immunodeficiency Virus - metabolism Nef protein Plasma Science Science (multidisciplinary) Viral Load - genetics Viral Load - physiology Viremia Viremia - metabolism Viremia - virology Virions Virus Replication - genetics Virus Replication - physiology |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB7BIiQuqDxaArRyJW7UbR52nByqqkJFC1K5wCJukRPbIhJkYbOw7L_vOE6CtjwOOUT2OLFnJvM5ngfAQaQMGl2VUO3LnDI0CVQGgaQmFb6KI4061nj5nsXDETu94ldL0JU7ahewfnVrZ-tJjSY335_u579Q4X-6kPHkR41GyAaK4UYItUVwOluGFbRMwlY0-NvCfZfrO0xZkLaxM6-TLtqnF6Dzpe_kfweojV06_gDrLaAkv50EbMCSrjZh1ZWYnG9BfYL6jp81RVxC7jkZG3KmDZmOSVMnQtswKXJuU0sdcVLWRLYMQxL7k5ZMbHJXvLlDnH0rySMOdltKUlZkeHJJnTMXNpd9ZFe9DaPjPxdHQ9oWWqAFE2xKEeMkXIVKc6GZ0IGvjFaMSeXzQuiEFSpHXKFNoU1iAmY4L8IiRfvHIuRmwaOPMKjGld4BksuYI4XwTZIwE0scIw95xJUUaWwC7UHQLW9WtFnIbTGMm6w5DY-SzLEkQ5ZkDUuymQeHPc2dy8Hxbu_9jmtZJ05ZiDaYc7xSD772zahJ9nhEVnr8YPvYSkQcEZMHnxyT-8dFCLMiP8UWscD-voPN0r3YUpXXTbZuEds9pu_Bt05Qnl_r7Vnsvj-LPVgLrdA2_oj7MJhOHvRnREfT_Esj8v8AxnAMgw priority: 102 providerName: Scholars Portal – databaseName: HAS SpringerNature Open Access 2022 dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RVpV6QTz6CC8ZqTdqNYntODmuEGh3D3sBKm6RE9tqpJJFZCni3zN2Hmi7BYlDDtF4HCfjyYztmW8AvjNt0ejqlJpQFZSjSaAqihS1mQx1wgzqmI_ynSeTaz67ETcbEPe5MD5o30Na-t90Hx32s0FD45LBcLGDGiEFffwAIwfVjnN7NB7PLmfDzoo7u-JR1mXIhCz9D_OqFVpzLdcjJP85JvXW52Ibtjq3kYzbge7Ahql34WNbSPJpD5opajX-vDRpYbefyMKSubFkuSC-GoRxyVDk0gFInQlSNUR1YkEWtxVL7h2EK97coTd9q8hf7Oy2UqSqyWT6i7YhW0iuhvyt5jNcX5xfnU1oV06BllzyJUVPJhU61kZIw6WJQm2N5lzpUJTSpLzUBXoPxpbGpjbiVogyLjO0cpyhzErBvsBmvajNNyCFSgRyyNCmKbeJwj6KWDChlcwSG5kAov7z5mWHNe5KXvzJ_Zk3S_NWJDmKJPciyR8DOB147lqkjTdbH_ZSyzuta_IYLa0QeGUBnAxk1Bd3CKJqs3hwbVy9IYF-UQBfWyEPj2PoTLEwQ4pcEf_QwGFxr1Lq6rfH5JaJW0mGAfzoJ8rLsF5_i_33NT-AT7GbxD4K8RA2l_cP5gh9omVx3CnBM6gkCMQ priority: 102 providerName: Springer Nature |
Title | Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals |
URI | https://link.springer.com/article/10.1038/s41598-020-76375-w https://www.ncbi.nlm.nih.gov/pubmed/33173092 https://www.proquest.com/docview/2471557159 https://www.proquest.com/docview/2459625822 https://pubmed.ncbi.nlm.nih.gov/PMC7656250 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgExIviG8CozISb2Atie3YeUKl2tRVokKMob5Fjj9EJJaUpWPaf8_ZcTOViT0kUWM7TfK7813uzncIvafGgdA1kthU1YSBSCAqyxRxpUhNQS3wWIjyXRbzM7ZY8VU0uPUxrHI7J4aJ2nTa28gPc5hFOYet_LT-TXzVKO9djSU07qN9n7rMU7VYidHG4r1YLCvjWpmUysMe5JVfUwbfTMBYgpOrXXl0S8m8HSv5j8M0yKHjx-hRVCDxdED8Cbpn26fowVBS8voZ6k-Av2EaM3hIwH2NO4eX1uFNh0NdCOuXReFTn0pqxnHTYxUBgiHeKIsvfDJX-LEGvfpc4T9wsfNG4abF85MfZAjeguZmXMnVP0dnx0ffZ3MSCysQzQTbENBpJDe5sVxYJmyWGmcNY8qkXAsrmTY16BHWaeuky5jjXOe6BHnHKKCnOX2B9tquta8QrlXBYYRInZTMFQquUeeccqNEWbjMJijbvt5Kx6zjvvjFryp4v6msBkgqgKQKkFRXCfowjlkPOTfu7H2wRa2K_NdXN9SSoHdjM3COd4eo1naXvo-vPMRBQ0rQywHk8e8oqFU0LaFF7MA_dvBZuXdb2uZnyM4tCv9NmSbo45ZQbm7r_0_x-u6neIMe5p5oQ_zhAdrbXFzat6ANbepJIPkJ2p9OF6cLOH4-Wn79BmdnxWwSLAyw_8LkX2chDuM |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw9KkqQnBB7A0UMBKcwGoWO04OCKFCNUPLXGjR3IIT2yISTYZmymh-im_kvWzVUNFbDzlEthPbb7XfBvAqMg6Frkm49XXOBYoEroNAc5cq38SRRRprvXxn8eREfJ7L-Rb8GWJhyK1y4IktozZ1QXfkeyFyUSnxSd8vfnGqGkXW1aGERocWh3a9wiNb8276EeH7OgwPPh3vT3hfVYAXQoklR4GeSBMaK5UVyga-cdYIoY0vC2UTUZgchah1hXWJC4STsgiLFJm9iHDqBVWJQJZ_AwWvT4c9NVfjnQ5ZzUSQ9rE5fpTsNSgfKYYNz2hIyEry1ab8u6TUXvbN_MdA28q9g7twp1dY2YcOw-7Blq3uw82uhOX6ATRT5CfINg3rEn6vWe3YzDq2rFlbh8JSGBb7Sqmr9iUrG6Z7hMAhdAnMzih5LL4sUI8_1ew3fuy01Kys2GT6jXfOYthcjpFjzUM4uZYtfwTbVV3ZHWC5jiWOUL5LEuFijd_IQxlJo1Uau8B6EAzbmxV9lnMqtvEza63tUZJ1IMkQJFkLkmzlwZtxzKLL8XFl790BallP7012gZ0evBybkVLJ_KIrW59TH6p0JFEj8-BxB-TxdxGqcZGfYovaAP_YgbKAb7ZU5Y82G7iK6Qzre_B2QJSLaf1_FU-uXsULuDU5_nKUHU1nh0_hdkgI3Po-7sL28uzcPkNNbJk_b9Gfwffrpre_uqZG6A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw9KmaCsQFsRMoYCQ4gTVZ7Dg5IARtRzMUjSqgqDfXiW0RiSZDM2U0v8bX8ZytGip66yGHyEtiv9V-G8CrSFsUujqhxlcZZSgSqAoCRW0qfB1HBmms8fKdx9Mj9umYH2_Bnz4WxrlV9jyxYdS6yt0d-ThELso5PunYdm4Rh3uT94tf1FWQcpbWvpxGiyIHZr3C41v9braHsH4dhpP9b7tT2lUYoDkTbElRuCdch9pwYZgwga-t0Ywp7fNcmITlOkOBamxubGIDZjnPwzxFxs8iXEbuKkYg-98W7lQ0gu2P-_PDL8MNj7OhsSDtInX8KBnXKC1dRBue2JCsBaerTWl4ScW97Kn5j7m2kYKTO3C7U1_Jhxbf7sKWKe_Bjbag5fo-1DPkLshENWnTf69JZcncWLKsSFOVwrigLPLVJbLa5aSoierQA4e4K2Fy5lLJ4ssCtfpTRX7jZKeFIkVJprPvtHUdw-ZiiCOrH8DRtWz6QxiVVWkeA8lUzHGE8G2SMBsrnCMLecS1EmlsA-NB0G-vzLuc5670xk_Z2N6jRLYgkQgS2YBErjx4M4xZtBk_ruy900NNdtRfywtc9eDl0Ix064wxqjTVuevj6h5x1M88eNQCefhchEpd5KfYIjbAP3RwOcE3W8riR5MbXMTuROt78LZHlIvf-v8qnly9ihdwE2lNfp7ND57CrdDhb-MIuQOj5dm5eYZq2TJ73uE_gZPrJrm_b2JMgw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+ability+of+Nef+to+counteract+SERINC5+is+associated+with+reduced+plasma+viremia+in+HIV-infected+individuals&rft.jtitle=Scientific+reports&rft.au=Toyoda+Mako&rft.au=Kamori+Doreen&rft.au=Tan%2C+Toong+Seng&rft.au=Kageaki%2C+Goebuchi&rft.date=2020-11-10&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-020-76375-w&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |